Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Boston Biomedica, Inc. (NasdaqNM:BBII)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials
Location
375 West Street
West Bridgewater, MA 02379
Phone: (508) 580-1900
Fax: (508) 580-0250
Employees (last reported count): 259
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Employment
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 41%
·Over the last 6 months:
 · 6 insider buys; 9,000  shares (0.4% of insider shares)
·Institutional: 4% (7% of float)
(15 institutions)
·Net Inst. Buying: 4,000  shares (+1.63%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Boston Biomedica, Inc. and its wholly owned subsidiaries provide products and services for the detection and treatment of infectious diseases such as AIDS and Viral Hepatitis. As of March 1, 2001, the Company had three business units: BBI Diagnostics, a manufacturer of quality control and other diagnostic products used to increase the accuracy of in vitro diagnostic tests; BBI Biotech Research Laboratories, the research and development arm of the Company, which supplements its support for the other BBI business units with research contracts and repository services primarily for agencies of the United States government; and BBI Source Scientific, a manufacturer of laboratory and medical instruments.
More from Market Guide: Expanded Business Description

Financial Summary
Boston Biomedica, Inc. is a provider of proprietary quality control products for use with in vitro diagnostic test kits for the detection, analysis and monitoring of infectious diseases. For the six months ended 6/01, revenues rose 4% to $10.5 million. Net loss from continuing operations fell 49% to $449 thousand. Results reflect increased sales in the Laboratory Instrumentation segment, higher repository service revenues and a reduction in interest and administrative expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Richard Schumacher, 50
Chairman and CEO
$236K$288K
Kevin Quinlan, 51
Pres, COO
183K--  
Patricia Garrett, Ph. D., 57
Sr. VP - Strategic Programs
128K68K
Mark Manak, Ph. D., 49
Sr. VP and Gen. Mang. of BBI Biotech
138K--  
David Petersen, 54
Sr. VP and Gen. Mang. of BBI Source
--  --  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:BBIIAs of 31-Aug-2001
Price and Volume
52-Week Low
on 22-Mar-2001
$0.75 
Recent Price$3.02 
52-Week High
on 12-Sep-2000
$7.125
Beta0.19 
Daily Volume (3-month avg)21.4K
Daily Volume (10-day avg)9,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-24.5%
52-Week Change
relative to S&P500
+1.3%
Share-Related Items
Market Capitalization$18.3M
Shares Outstanding6.06M
Float3.60M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$2.04 
Earnings (ttm)-$1.16 
Earnings (mrq)$0.01 
Sales (ttm)$3.17 
Cash (mrq)$0.31 
Valuation Ratios
Price/Book (mrq)1.48 
Price/EarningsN/A 
Price/Sales (ttm)0.95 
Income Statements
Sales (ttm)$19.9M
EBITDA (ttm)-$2.33M
Income available to common (ttm)-$7.18M
Profitability
Profit Margin (ttm)-36.1%
Operating Margin (ttm)-19.9%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-31.97%
Return on Equity (ttm)-69.11%
Financial Strength
Current Ratio (mrq)2.88 
Debt/Equity (mrq)0.20 
Total Cash (mrq)$1.87M
Short Interest
As of 8-Aug-2001
Shares Short6,000 
Percent of Float0.2%
Shares Short
(Prior Month)
1,000 
Short Ratio0.21 
Daily Volume28.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.